Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Liberate Medical | INDUSTRY |
| Amsterdam UMC, location VUmc | OTHER |
| Canisius-Wilhelmina Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Patients requiring prolonged time on the ventilator are susceptible to a wide range of clinical complications and excess mortality. It is therefore imperative for them to wean at the earliest possible time.
Respiratory muscle weakness due to disuse of these muscles is a major underlying factor for weaning failure. Surprisingly, there is not much known about the impact of critical illness and MV on the expiratory abdominal wall muscles.These muscles are immediately activated as ventilation demands increase and are important in supporting respiratory function in patients with diaphragm weakness. Weakness of expiratory abdominal wall muscles will result in a decreased cough function and reduced ventilatory capacity. These are considerable causes of weaning failure and (re)hospitalisation for respiratory complications such as pneumonia.
Recent evidence shows that neuromuscular electrical stimulation (NMES) can be used as a safe therapy to maintain skeletal muscle function in critically ill patients. This study will be the first to test the hypothesis that breath-synchronized NMES of the abdominal wall muscles can prevent expiratory muscle atrophy during the acute stages of MV.
Approximately 30-40% of intubated patients at the intensive care unit (ICU) take more than one attempt to wean from mechanical ventilation (MV). 6-14% of intubated patients take longer than 7 days to wean from MV. Patients requiring prolonged time on the ventilator are susceptible to a wide range of clinical complications and excess mortality. It is therefore imperative for them to wean at the earliest possible time.
Respiratory muscle weakness due to disuse of these muscles is a major underlying factor for weaning failure. It is known that diaphragm strength rapidly declines within a few days after the initiation of MV. Surprisingly, there is not much known about the impact of critical illness and MV on the expiratory abdominal wall muscles.These muscles are immediately activated as ventilation demands increase and are important in supporting respiratory function in patients with diaphragm weakness. Weakness of expiratory abdominal wall muscles will result in a decreased cough function and reduced ventilatory capacity. These are considerable causes of weaning failure and (re)hospitalisation for respiratory complications such as pneumonia.
Recent evidence shows that neuromuscular electrical stimulation (NMES) can be used as a safe therapy to maintain skeletal muscle function in critically ill patients, e.g. by stimulating quadriceps muscles in patients receiving MV.
This study will be the first to test the hypothesis that exhalation synchronized NMES of the abdominal wall muscles can prevent expiratory muscle atrophy during the acute stages of MV. The investigators hypothesize that this approach will improve respiratory function and thereby will reduce the amount of time it takes to wean patients from mechanical ventilation.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| VF03-K active stimulation | Experimental | NMES applied to the abdominal wall muscles using the VentFree prototype (VF03-K). Stimulation is applied twice daily for 30 minutes, 5 days per week, for 6 weeks or until the patient is weaned from mechanical ventilation, whichever occurs sooner. |
|
| VF03-K sham stimulation | Sham Comparator | Sham stimulation applied to the abdominal wall muscles using the VentFree prototype (VF03-K). Sham stimulation is applied twice daily for 30 minutes, 5 days per week, for 6 weeks or until the patient is weaned from mechanical ventilation, whichever occurs sooner. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| VentFree prototype (VF03-K) active stimulation | Device | Abdominal wall muscle stimulation synchronised with mechanical ventilation. Stimulation frequency: 30 Hz, pulse width: 352us, max. intensity: 100mA (threshold intensity determined using ultrasound) |
| Measure | Description | Time Frame |
|---|---|---|
| Thickness of the abdominal wall muscles | Thickness of the abdominal wall muscles over time, for both groups, as measured by ultrasound. | Until study completion, up to 6 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Thickness of the diaphragm | Thickness of the diaphragm over time, for both groups, as measured by ultrasound. | Until study completion, up to 6 weeks |
| Thickness of the rectus abdominis muscle | Thickness of the rectus abdominis mucle over time, for both groups, as measured by ultrasound. |
| Measure | Description | Time Frame |
|---|---|---|
| Expiratory flow limitation (optional) | EFL test to determine flow limitation in COPD | Measured before the first NMES session and within 24 hours after extubation |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Leo MA Heunks, MD, Prof | Contact | 0204442209 | l.heunks@vumc.nl | |
| Annemijn H Jonkman, MSc | Contact | 0204442209 | ah.jonkman@vumc.nl |
| Name | Affiliation | Role |
|---|---|---|
| Angelique ME Spoelstra-de Man, MD, PhD | Amsterdam UMC, location VUmc | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UMC Nijmegen | Recruiting | Nijmegen | Gelderland | 6525 GA | Netherlands |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33126902 | Derived | Jonkman AH, Frenzel T, McCaughey EJ, McLachlan AJ, Boswell-Ruys CL, Collins DW, Gandevia SC, Girbes ARJ, Hoiting O, Kox M, Oppersma E, Peters M, Pickkers P, Roesthuis LH, Schouten J, Shi ZH, Veltink PH, de Vries HJ, Shannon Weickert C, Wiedenbach C, Zhang Y, Tuinman PR, de Man AME, Butler JE, Heunks LMA. Breath-synchronized electrical stimulation of the expiratory muscles in mechanically ventilated patients: a randomized controlled feasibility study and pooled analysis. Crit Care. 2020 Oct 30;24(1):628. doi: 10.1186/s13054-020-03352-0. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| VentFree prototype (VF03-K) sham stimulation | Device | Abdominal wall muscle sham-stimulation synchronised with mechanical ventilation. Stimulation frequency: 10 Hz, pulse width: 352us, intensity: 15 mA. |
|
| Until study completion, up to 6 weeks |
| Maximum expiratory pressure (MEP) | Maximum expiratory pressure (MEP) to assess expiratory muscle function | Within 24 hours after extubation |
| Maximum inspiratory pressure (MIP) | Maximum inspiratory pressure (MIP) to assess inspiratory muscle function | Within 24 hours after extubation |
| Vital capacity (Vc) | Vital capacity (Vc) to assess respiratory muscle strength | Within 24 hours after extubation |
| Peak expiratory flow | Peak expiratory flow (PEF) to assess cough strength | Within 24 hours after extubation |
| Number of patients with extubation failure | Weaning failure defined as the failure to pass a spontaneous-breathing trial or the need for reintubation within 48 hours following extubation | Within 24 hours after extubation |
| Systemic inflammatory markers | Among others, cytokines IL-6 and IL-1 will be determined from blood sample analysis | Within 24 hours after extubation |
| Number of patients with respiratory complications after ICU discharge | Number of patients with development of pneumonia, and readmission to the ICU due to atelectasis or respiratory problems that require mechanical ventilation. | Up to 6 weeks after ICU discharge |
| Canisius Wilhelmina Hospital | Recruiting | Nijmegen | Gelderland | 6532 SZ | Netherlands |
|
| VU University Medical Center | Recruiting | Amsterdam | North Holland | 1081 HV | Netherlands |
|
| ID | Term |
|---|---|
| D018908 | Muscle Weakness |
| D053120 | Respiratory Aspiration |
| ID | Term |
|---|---|
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D020879 | Neuromuscular Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012816 | Signs and Symptoms |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided